BioAffinity Technologies today announced it appointed J. Michael Edwards as chief financial officer. Edwards became interim CFO in September following Michael Dougherty’s resignation to take on a CFO role in the Pacific Northwest energy industry. He previously served as BioAffinity’s consulting CFO from 2014 to 2023 and oversaw the company’s initial public offering in 2022. […]
BioAffinity Technologies
BioAffinity Technologies CFO resigns to take on similar role in energy industry
BioAffinity Technologies recently announced that CFO Michael Dougherty has resigned, and J. Michael Edwards was appointed interim CFO. Dougherty is resigning to take on a CFO position in the Pacific Northwest energy industry. He will continue to serve in his role until September 15 and will assist in the transition. BioAffinity Technologies appointed him as […]
BioAffinity Technologies names Michael Dougherty as CFO
BioAffinity Technologies today announced it appointed Michael Dougherty as chief financial officer, effective immediately. Dougherty will report directly to President and CEO Maria Zannes. He has more than 20 years of experience in financial management and business strategy. Former CFO Michael Edwards will remain as a consultant to ensure a smooth transition. “We are delighted […]
Smiths Medical, bioAffinity partner on cancer diagnostic
BioAffinity Technologies and Smiths Medical announced today that they are partnering to improve care with at-home collection of sputum. San Antonio-based BioAffinity’s CyPath Lung, a non-invasive flow cytometry diagnostic test for lung cancer, is set to be used in the partnership to analyze the at-home collection of sputum, according to a news release. Patients are […]
BioAffinity Technologies CEO Maria Zannes talks cancer detection, women in medtech
Maria Zannes and her company BioAffinity Technologies are seeking to up the game on lung cancer detection. Here’s how. Maria Zannes’ path to a leading role in the medtech field wasn’t quite a conventional one. The one-time aspiring journalist carved out a role on Capitol Hill, first as an aide, then as a lobbyist, plus […]
